Recent Finacing
Recent Raise
Viva In Vitro develops a compact cartridge-based diagnostic device (Viva Sepscare) that detects NLRP3 inflammasome activation to stratify sepsis patients, pursuing clinical validation, regulatory approval, and pharma partnerships.
